相关实验视频
Updated: Sep 19, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.2K
探索激素和放射治疗在乳腺癌观察性研究中的因果作用,使用基于的半竞争性风险模型
Tonghui Yu1, Mengjiao Peng2, Yifan Cui3
1School of Physical and Mathematical Sciences, Nanyang Technological University, Singapore, Singapore.
Statistics in medicine
|June 4, 2025
概括
这项研究引入了一个新的统计框架来分析乳腺癌的结果,解决半竞争性风险,以便更准确地评估治疗效果. 该方法增强了患者生存数据的因果推断和灵敏度分析.
科学领域:
- 生物统计学 生物统计学
- 医学统计 医学统计
- 生存分析的分析.
背景情况:
- 乳腺癌患者在手术后面临复发或死亡,这种现象被称为半竞争性风险.
- 在半竞争性风险场景中分析治疗效应需要先进的统计方法来获得公正的结果.
- 目前用于半竞争性风险回归的因果推断应用有限.
研究的目的:
- 提出一种新的频率学和半参数学框架,用于在半竞争性风险数据中的因果推理.
- 为了能够对净量进行有效的估计和解释,并对未测量的因素进行敏感性分析.
- 加强参数估计和乳腺癌研究中的实际应用.
主要方法:
- 开发一个基于copula的框架,用于正确审查的半竞争性风险数据.
- 引入用于参数估计和实际应用的新程序.
- 应用到乳腺癌数据集,以分析时间变化的治疗效果.
主要成果:
- 拟议的框架有助于有效的因果推断和敏感性分析.
- 新的程序改善了参数估计和实际应用.
- 应用揭示了激素和放射治疗对乳腺癌复发和生存的因果关系.
结论:
- 开发的统计框架为半竞争性风险中的因果推理提供了强有力的方法.
- 广泛的评估证实了该方法的可行性,最小偏差和可靠的推断.
- 这项研究推进了乳腺癌存活率研究中治疗效应的分析.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
Comparing the Survival Analysis of Two or More Groups
303
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
303
Criteria for Causality: Bradford Hill Criteria - II
682
The Bradford Hill criteria serve as guidelines for establishing causative links in epidemiological research. Beyond Strength, Consistency, Specificity, and Temporality, key criteria also include Biological Gradient, Plausibility, Coherence, Experiment, and Analogy. These principles assist scientists in assessing the likelihood of causation in complex biological contexts. Below is a summary of these concepts:
682
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Causality in Epidemiology
920
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
920
Hazard Ratio
263
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
263

